 | Study programme 2021-2022 | Français | |
 | Drugs & Strategies for Cancer Treatment | ||
Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-016-M | Optional UE | JOURNE Fabrice | M112 - Anatomie humaine et Oncologie expérimentale |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Anglais | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-ANBC-300 | Drugs & Strategies for Cancer Treatment - Part 1 | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
Chemotherapy, hormone therapy, targeted therapy and immunotherapy. The course will be teached in english.
Content of UE
This course will develop the systemic treatment of cancer including chemotherapy, hormone therapy, targeted therapies (against signaling pathways and mutations), and immunotherapy. Cancer chemotherapy uses drugs that interfere with cell growth leading to cell death (cytotoxic drugs) or stopping cell proliferation (cytostatic drugs). This course will also discuss the importance of multidrug therapy. In the context of integrative oncology, the coordination of care between the pharmacist, the doctor and the hospital is important. The efficacy of anticancer treatments and the associated adverse effects will be discussed, in particular concerning the dermatological toxicity of oncological treatments. Finally, the role of pharmacists in supportive care will be presented.
Prior Experience
Not applicable
Type of Assessment for UE in Q1
- Oral examination
Q1 UE Assessment Comments
/
Type of Assessment for UE in Q3
- Oral examination
Q3 UE Assessment Comments
/
Type of Resit Assessment for UE in Q1 (BAB1)
- N/A
Q1 UE Resit Assessment Comments (BAB1)
/
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-ANBC-300 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-ANBC-300 |
|
Required Reading
| AA | |
|---|---|
| M-ANBC-300 |
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-ANBC-300 | Not applicable |
Recommended Reading
| AA | |
|---|---|
| M-ANBC-300 |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-ANBC-300 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-ANBC-300 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-ANBC-300 | Authorized |